Multimodality treatment of stage II thymic tumours

Thymic tumors are relatively rare neoplasms arising from the epithelial thymic cells. They show a significant histological heterogeneity and clinical behavior ranging from an indolent non-invasive attitude to a highly infiltrative and metastasizing one. Prognosis is affected by the Masaoka-Koga staging, the World Health Organization (WHO) histological classification, completeness of resection, the diameter of the lesion and the presence of vascular invasion (1-8)